![Conny Börje Bogentoft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Conny Börje Bogentoft
Direktor/Vorstandsmitglied bei
Galenica AB
Profil
Conny Börje Bogentoft is currently a Director at Galenica AB since 2008.
Prior to this, he served as the Chief Executive Officer at Karolinska Development AB (Private Equity) from 2003 to 2010.
He also held director positions at various firms including Promore Pharma AB, Omnio Healer AB, PharmaSurgics In Sweden AB, Umecrine AB, and Lipidor AB.
Aktive Positionen von Conny Börje Bogentoft
| Unternehmen | Position | Beginn |
|---|---|---|
Galenica AB
 Galenica AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical drugs | Direktor/Vorstandsmitglied | 01.01.2008 |
Ehemalige bekannte Positionen von Conny Börje Bogentoft
| Unternehmen | Position | Ende |
|---|---|---|
Omnio Healer AB
 Omnio Healer AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Direktor/Vorstandsmitglied | 19.01.2012 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Präsident | 23.08.2010 |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Direktor/Vorstandsmitglied | - |
Umecrine AB
 Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Direktor/Vorstandsmitglied | - |
| LIPIDOR AB | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Health Technology |
Omnio Healer AB
Omnio Healer AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Umecrine AB
Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Commercial Services |
Lipidor AB
 Lipidor AB Miscellaneous Commercial ServicesCommercial Services Develops and commercializes lipid-based topical medication products | Commercial Services |
Galenica AB
Galenica AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical drugs | Health Technology |
